
Jeffrey Nau named CEO of Aviceda Therapeutics
Aviceda Therapeutics recently appointed Jeffrey Nau, PhD, MMS, as chief executive officer. Nau comes to Aviceda with more than 20 years of experience leading and expanding biotechnology and pharmaceutical companies.1 In his most recent role as chief …